Recent Posts

Notas del Blog

24/09/2018
Adding ATG to PTCy: the next step?

Chronic graft versus host disease (cGVHD) is the major factor limiting quality of life for allogeneic transplant recipients who have

Read More
16/07/2018
Can we change the dismal future of relapsed AML patients?

While acute myeloid leukemia (AML) patients have a chance for long-term remission and cure, some of them will not attain

Read More
10/04/2018
ITP in children and adults: not so different after all.

Around 80% of children with ITP are disease-free within 1 year; a watch and wait strategy is considered standard for

Read More
09/04/2018
How I treat multiple myeloma when resources are scarce.

dexamethasone and adriamycin. Results were bad, the median survival was around two years. In the 1990s something good happened; thalidomide

Read More
09/04/2018
The changing landscape of mantle cell lymphoma.

Mantle cell lymphoma (MCL) is a B-cell malignancy with an inferior prognosis in comparison to other lymphomas. Most patients present

Read More
26/03/2018
Welcome!

Developing Hematology is a blog written for medical professionals who practice clinical hematology in developing countries We aim to offer

Read More
crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram